Cargando…

Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma

Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomomasa, Ran, Arai, Yasuhito, Kawabata‐Iwakawa, Reika, Fukuoka, Kohei, Nakano, Yoshiko, Hama, Natsuko, Nakata, Satoshi, Suzuki, Nozomi, Ishi, Yukitomo, Tanaka, Shinya, Takahashi, Jun A., Yuba, Yoshiaki, Shiota, Mitsutaka, Natsume, Atsushi, Kurimoto, Michihiro, Shiba, Yoshiki, Aoki, Mikiko, Nabeshima, Kazuki, Enomoto, Toshiyuki, Inoue, Tooru, Fujimura, Junya, Kondo, Akihide, Yao, Takashi, Okura, Naoki, Hirose, Takanori, Sasaki, Atsushi, Nishiyama, Masahiko, Ichimura, Koichi, Shibata, Tatsuhiro, Hirato, Junko, Yokoo, Hideaki, Nobusawa, Sumihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412126/
https://www.ncbi.nlm.nih.gov/pubmed/33576087
http://dx.doi.org/10.1111/bpa.12943
_version_ 1783747397031034880
author Tomomasa, Ran
Arai, Yasuhito
Kawabata‐Iwakawa, Reika
Fukuoka, Kohei
Nakano, Yoshiko
Hama, Natsuko
Nakata, Satoshi
Suzuki, Nozomi
Ishi, Yukitomo
Tanaka, Shinya
Takahashi, Jun A.
Yuba, Yoshiaki
Shiota, Mitsutaka
Natsume, Atsushi
Kurimoto, Michihiro
Shiba, Yoshiki
Aoki, Mikiko
Nabeshima, Kazuki
Enomoto, Toshiyuki
Inoue, Tooru
Fujimura, Junya
Kondo, Akihide
Yao, Takashi
Okura, Naoki
Hirose, Takanori
Sasaki, Atsushi
Nishiyama, Masahiko
Ichimura, Koichi
Shibata, Tatsuhiro
Hirato, Junko
Yokoo, Hideaki
Nobusawa, Sumihito
author_facet Tomomasa, Ran
Arai, Yasuhito
Kawabata‐Iwakawa, Reika
Fukuoka, Kohei
Nakano, Yoshiko
Hama, Natsuko
Nakata, Satoshi
Suzuki, Nozomi
Ishi, Yukitomo
Tanaka, Shinya
Takahashi, Jun A.
Yuba, Yoshiaki
Shiota, Mitsutaka
Natsume, Atsushi
Kurimoto, Michihiro
Shiba, Yoshiki
Aoki, Mikiko
Nabeshima, Kazuki
Enomoto, Toshiyuki
Inoue, Tooru
Fujimura, Junya
Kondo, Akihide
Yao, Takashi
Okura, Naoki
Hirose, Takanori
Sasaki, Atsushi
Nishiyama, Masahiko
Ichimura, Koichi
Shibata, Tatsuhiro
Hirato, Junko
Yokoo, Hideaki
Nobusawa, Sumihito
author_sort Tomomasa, Ran
collection PubMed
description Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentiation (ELTMDs),” harboring C11orf95‐NCOA1/2 or ‐RELA fusion. We examined the clinicopathological and molecular features in five cases of ELTMDs. Except for one adult case (50 years old), all cases were in children ranging from 1 to 2.5 years old. All patients presented with a mass lesion in the cerebral hemisphere. Histologically, all cases demonstrated a similar histology with a mixture of components. The major components were embryonal‐appearing components forming well‐delineated tumor cell nests composed of small uniform cells with high proliferative activity, and spindle‐cell mesenchymal components with a low‐ to high‐grade sarcoma‐like appearance. The embryonal‐appearing components exhibited minimal ependymal differentiation including a characteristic EMA positivity and tubular structures, but histologically did not fit with ependymoma because they lacked perivascular pseudorosettes, a histological hallmark of ependymoma, formed well‐delineated nests, and had diffuse and strong staining for CAM5.2. Molecular analysis identified C11orf95‐NCOA1, ‐NCOA2, and ‐RELA in two, one, and two cases, respectively. t‐distributed stochastic neighbor embedding analysis of DNA methylation data from two cases with C11orf95‐NCOA1 or ‐NCOA2 and a reference set of 380 CNS tumors revealed that these two cases were clustered together and were distinct from all subgroups of ependymomas. In conclusion, although ELTMDs exhibited morphological and genetic associations with supratentorial ependymoma with C11orf95‐RELA, they cannot be regarded as ependymoma. Further analyses of more cases are needed to clarify their differences and similarities.
format Online
Article
Text
id pubmed-8412126
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84121262021-09-03 Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma Tomomasa, Ran Arai, Yasuhito Kawabata‐Iwakawa, Reika Fukuoka, Kohei Nakano, Yoshiko Hama, Natsuko Nakata, Satoshi Suzuki, Nozomi Ishi, Yukitomo Tanaka, Shinya Takahashi, Jun A. Yuba, Yoshiaki Shiota, Mitsutaka Natsume, Atsushi Kurimoto, Michihiro Shiba, Yoshiki Aoki, Mikiko Nabeshima, Kazuki Enomoto, Toshiyuki Inoue, Tooru Fujimura, Junya Kondo, Akihide Yao, Takashi Okura, Naoki Hirose, Takanori Sasaki, Atsushi Nishiyama, Masahiko Ichimura, Koichi Shibata, Tatsuhiro Hirato, Junko Yokoo, Hideaki Nobusawa, Sumihito Brain Pathol Research Articles Recurrent fusion genes involving C11orf95, C11orf95‐RELA, have been identified only in supratentorial ependymomas among primary CNS tumors. Here, we report hitherto histopathologically unclassifiable high‐grade tumors, under the tentative label of “ependymoma‐like tumors with mesenchymal differentiation (ELTMDs),” harboring C11orf95‐NCOA1/2 or ‐RELA fusion. We examined the clinicopathological and molecular features in five cases of ELTMDs. Except for one adult case (50 years old), all cases were in children ranging from 1 to 2.5 years old. All patients presented with a mass lesion in the cerebral hemisphere. Histologically, all cases demonstrated a similar histology with a mixture of components. The major components were embryonal‐appearing components forming well‐delineated tumor cell nests composed of small uniform cells with high proliferative activity, and spindle‐cell mesenchymal components with a low‐ to high‐grade sarcoma‐like appearance. The embryonal‐appearing components exhibited minimal ependymal differentiation including a characteristic EMA positivity and tubular structures, but histologically did not fit with ependymoma because they lacked perivascular pseudorosettes, a histological hallmark of ependymoma, formed well‐delineated nests, and had diffuse and strong staining for CAM5.2. Molecular analysis identified C11orf95‐NCOA1, ‐NCOA2, and ‐RELA in two, one, and two cases, respectively. t‐distributed stochastic neighbor embedding analysis of DNA methylation data from two cases with C11orf95‐NCOA1 or ‐NCOA2 and a reference set of 380 CNS tumors revealed that these two cases were clustered together and were distinct from all subgroups of ependymomas. In conclusion, although ELTMDs exhibited morphological and genetic associations with supratentorial ependymoma with C11orf95‐RELA, they cannot be regarded as ependymoma. Further analyses of more cases are needed to clarify their differences and similarities. John Wiley and Sons Inc. 2021-02-12 /pmc/articles/PMC8412126/ /pubmed/33576087 http://dx.doi.org/10.1111/bpa.12943 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Tomomasa, Ran
Arai, Yasuhito
Kawabata‐Iwakawa, Reika
Fukuoka, Kohei
Nakano, Yoshiko
Hama, Natsuko
Nakata, Satoshi
Suzuki, Nozomi
Ishi, Yukitomo
Tanaka, Shinya
Takahashi, Jun A.
Yuba, Yoshiaki
Shiota, Mitsutaka
Natsume, Atsushi
Kurimoto, Michihiro
Shiba, Yoshiki
Aoki, Mikiko
Nabeshima, Kazuki
Enomoto, Toshiyuki
Inoue, Tooru
Fujimura, Junya
Kondo, Akihide
Yao, Takashi
Okura, Naoki
Hirose, Takanori
Sasaki, Atsushi
Nishiyama, Masahiko
Ichimura, Koichi
Shibata, Tatsuhiro
Hirato, Junko
Yokoo, Hideaki
Nobusawa, Sumihito
Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title_full Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title_fullStr Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title_full_unstemmed Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title_short Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95‐NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma
title_sort ependymoma‐like tumor with mesenchymal differentiation harboring c11orf95‐ncoa1/2 or ‐rela fusion: a hitherto unclassified tumor related to ependymoma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412126/
https://www.ncbi.nlm.nih.gov/pubmed/33576087
http://dx.doi.org/10.1111/bpa.12943
work_keys_str_mv AT tomomasaran ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT araiyasuhito ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT kawabataiwakawareika ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT fukuokakohei ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT nakanoyoshiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT hamanatsuko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT nakatasatoshi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT suzukinozomi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT ishiyukitomo ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT tanakashinya ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT takahashijuna ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT yubayoshiaki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT shiotamitsutaka ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT natsumeatsushi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT kurimotomichihiro ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT shibayoshiki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT aokimikiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT nabeshimakazuki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT enomototoshiyuki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT inouetooru ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT fujimurajunya ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT kondoakihide ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT yaotakashi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT okuranaoki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT hirosetakanori ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT sasakiatsushi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT nishiyamamasahiko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT ichimurakoichi ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT shibatatatsuhiro ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT hiratojunko ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT yokoohideaki ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma
AT nobusawasumihito ependymomaliketumorwithmesenchymaldifferentiationharboringc11orf95ncoa12orrelafusionahithertounclassifiedtumorrelatedtoependymoma